RegAlert™ Dashboard is an advanced AI-powered intelligence dashboard designed to enhance Pharmacovigilance Risk Reporting by ensuring compliance with 🍁 Health Canada's Foreign Risk Guidance under Section C.01.050 of the Food & Drug Regulations.
To enhance patient safety, an increasing number of regulatory authorities worldwide are implementing requirements for the timely reporting of foreign regulatory actions affecting drug substances and drug products.
By leveraging Automated Intelligence, Natural language Processing (NLP) , RegAlert™ streamlines risk monitoring, accelerates decision-making, and enhances regulatory alignment, empowering pharmaceutical companies to stay ahead in compliance.
In addition to monitoring global safety and risk communication updates, our platform now includes:
These additions give our clients both regulatory foresight and early competitor awareness — all within a unified, user-friendly interface.
📖 Read the Article to see how RegAlert™ transforms regulatory intelligence into actionable insights!
Simply let us know—we’ll grant you free trial access so you can explore the dashboard in full.
MedAlert™ Dashboard is a comprehensive medical literature analysis platform designed specifically for pharmaceutical companies to monitor, analyze, and extract insights from medical research publications.
Core Features
© 2025 Nascent Pharma Consulting. - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.